DaVita Inc.
DVA NYSEHealthcare ★★★★★Latest Earnings
Date
Aug 4, 2026
ET
EPS Est.
3.88
EPS Actual
4.02
Revenue Est.
$3.5B
Revenue Actual
$3.55B
Next Earnings Report Date unconfirmed
Date
Oct 28, 2026 · Wed
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
3.58
Revenue Est.
$3.51B
Company Overview
DaVita Inc. (ticker DVA) is listed on NYSE with a market cap of about $11.16B. Its next earnings report (FY2026 Q3) is expected on Oct 28, 2026 (ET), After-market (date pending company confirmation), with consensus EPS of 3.58. In the last 15 reported quarters, EPS beat consensus estimates 12 times.
Actual EPS TrendRecently15Term · Feb 22, 2023 → Aug 4, 2026
Feb 22, 2023Range: 1.11 ~ 4.02Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 3.88 | 4.02 | $3.5B | $3.55B |
| May 5, 2026 | -- | 2.41 | Above forecast↑2.87 | $3.36B | $3.42B |
| Feb 2, 2026 | -- | 3.24 | 3.40 | $3.51B | $3.62B |
| Oct 29, 2025 | -- | 3.17 | Below forecast↓2.51 | $3.43B | $3.42B |
| Aug 5, 2025 | -- | 2.70 | 2.95 | $3.44B | $3.38B |
| May 12, 2025 | -- | 1.95 | 2.00 | $3.21B | $3.22B |
| Feb 13, 2025 | -- | 2.14 | 2.24 | $3.27B | $3.29B |
| Oct 29, 2024 | -- | 2.72 | 2.59 | $3.27B | $3.26B |
| Aug 6, 2024 | -- | 2.54 | 2.50 | $3.15B | $3.19B |
| May 2, 2024 | -- | 1.95 | Above forecast↑2.26 | $3.03B | $3.07B |
| Feb 13, 2024 | -- | 1.59 | 1.62 | $3.01B | $3.15B |
| Nov 7, 2023 | -- | 2.02 | Above forecast↑2.62 | $3.02B | $3.12B |
| Aug 3, 2023 | -- | 1.69 | 1.91 | $2.95B | $3B |
| May 8, 2023 | -- | 1.15 | 1.25 | $2.84B | $2.87B |
| Feb 22, 2023 | -- | 0.88 | Above forecast↑1.11 | $2.93B | $2.92B |
Original Filings (SEC)
10-Q2026-08-04 ↗
8-K2026-08-04 ↗
8-K2026-06-08 ↗
10-Q2026-05-05 ↗
8-K2026-05-05 ↗
10-K2026-02-11 ↗
8-K2026-02-02 ↗
8-K2025-11-25 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
